Impact of Imatinib Therapy on Immunometabolism to Promote β‐Cell Survival in Diabetes
Journal of Diabetes · 2026-07 · 18 (7)
DOI: 10.1111/1753-0407.70252 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Diabetes, online erschienen am 30.06.2026. Verfasst von Sandeep Kumar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Tulane University School of Medicine, New Orleans, Louisiana, USA. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Tulane University School of Medicine, New Orleans, Louisiana, USA.
ORCID-Profile: Sandeep Kumar
Zitieren
APA
Kumar, S., & Kumari, R. (2026). Impact of Imatinib Therapy on Immunometabolism to Promote β‐Cell Survival in Diabetes. Journal of Diabetes, 18(7). https://doi.org/10.1111/1753-0407.70252
Vancouver
Kumar S, Kumari R. Impact of Imatinib Therapy on Immunometabolism to Promote β‐Cell Survival in Diabetes. Journal of Diabetes. 2026;18(7). doi:10.1111/1753-0407.70252
BibTeX
@article{Kumar2026,
author = {Kumar, Sandeep and Kumari, Reena},
title = {Impact of Imatinib Therapy on Immunometabolism to Promote β‐Cell Survival in Diabetes},
journal = {Journal of Diabetes},
year = {2026},
volume = {18},
number = {7},
doi = {10.1111/1753-0407.70252}
}
EUVIMED